Grufity logo
Grufity logo

Latest ADAR1 Capital Management, LLC Stock Portfolio

$2.19Billion | No. of Holdings #262

ADAR1 Capital Management, LLC Performance

2026 Q2+11.04%
YTD+11.78%
2025+63.95%

About ADAR1 Capital Management, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, ADAR1 Capital Management, LLC reported an equity portfolio of $2.2 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of ADAR1 Capital Management, LLC are , PTGX, ROIV. The fund has invested 11% of it's portfolio in ABIVAX SA and 5.4% of portfolio in PROTAGONIST THERAPEUTICS INC. <br><br> The fund managers got completely rid off TERNS PHARMACEUTICALS INC (TERN), BEAM THERAPEUTICS INC (BEAM) and SCHOLAR ROCK HLDG CORP (SRRK) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX), MAPLIGHT THERAPEUTICS INC and SANOFI SA (SNY). ADAR1 Capital Management, LLC opened new stock positions in EDITAS MEDICINE INC (EDIT), VOR BIOPHARMA INC (VOR) and FAETH THERAPEUTICS INC (SNSE). The fund showed a lot of confidence in some stocks as they added substantially to PRAXIS PRECISION MEDICINES I (PRAX), RALLYBIO CORP (RLYB) and ENANTA PHARMACEUTICALS INC (ENTA).
ADAR1 Capital Management, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$2.19Billion
  as of Aug 14, 2026

ADAR1 Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ADAR1 Capital Management, LLC made a return of 11.04% in the last quarter. In trailing 12 months, it's portfolio return was 88.46%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
editas medicine inc28,800,400
vor biopharma inc12,530,300
faeth therapeutics inc9,025,250
ascendis pharma a/s7,629,260
amanat acquisition corp7,620,000
research alliance corp iii6,955,000
relay therapeutics inc6,704,410
disciplined growth5,020,000
New stocks bought by ADAR1 Capital Management, LLC

Additions

Ticker% Inc.
praxis precision medicines i4,850
rallybio corp4,411
enanta pharmaceuticals inc2,517
inflarx nv1,795
fulcrum therapeutics inc1,098
biohaven ltd1,020
leonabio inc957
whitehawk therapeutics inc943
Additions to existing portfolio by ADAR1 Capital Management, LLC

Reductions

Ticker% Reduced
moonlake immunotherapeutics-94.09
maplight therapeutics inc-92.93
sanofi sa-81.98
crescent biopharma inc.-63.65
ww intl inc-63.08
arbutus biopharma corp-59.53
replimune group inc-58.57
ars pharmaceuticals inc-55.86
ADAR1 Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
beam therapeutics inc-34,467,100
terns pharmaceuticals inc-48,222,900
scholar rock hldg corp-20,021,500
viridian therapeutics inc-5,954,490
mereo biopharma group plc-49,500
arrivent biopharma inc-3,271,650
karyopharm therapeutics inc-761,620
bioage labs inc-2,370,940
ADAR1 Capital Management, LLC got rid off the above stocks

Sector Distribution

ADAR1 Capital Management, LLC has about 64.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare64.9
Others34.2

Market Cap. Distribution

ADAR1 Capital Management, LLC has about 14.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
  • MICRO-CAP
Category%
UNALLOCATED34.2
MID-CAP29.1
LARGE-CAP14.2
SMALL-CAP13.7
MICRO-CAP7.3

Stocks belong to which Index?

About 39.3% of the stocks held by ADAR1 Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others60.7
RUSSELL 200037.5
S&P 5001.8
Top 5 Winners (%)%
OGN
organon & co
126.0 %
ACHV
achieve life science inc
108.0 %
oruka therapeutics inc
94.0 %
PSNL
personalis inc
88.3 %
URGN
urogen pharma ltd
85.7 %
Top 5 Winners ($)$
abivax sa
35.0 M
IMVT
immunovant inc
34.3 M
ROIV
roivant sciences ltd
24.8 M
PTGX
protagonist therapeutics inc
16.8 M
anteris technologies global
14.9 M
Top 5 Losers (%)%
ATHA
leonabio inc
-84.7 %
CNTX
context therapeutics inc
-73.2 %
CMPX
compass therapeutics inc
-55.0 %
a spac iii acquisition corp
-55.0 %
JSPR
jasper therapeutics inc
-52.0 %
Top 5 Losers ($)$
ATHA
leonabio inc
-39.4 M
INSM
insmed inc
-7.5 M
IVA
inventiva sa
-5.1 M
DBVT
dbv technologies s a
-3.5 M
FULC
fulcrum therapeutics inc
-3.4 M

ADAR1 Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC has 262 stocks in it's portfolio. About 40.8% of the portfolio is in top 10 stocks. ATHA proved to be the most loss making stock for the portfolio. was the most profitable stock for ADAR1 Capital Management, LLC last quarter.

$2.13BTotal Value
336Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of ADAR1 Capital Management, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AAXJ
Ishares Tr

Ishares Tr

AAXJ
ADAR1 Capital Management, LLC's holding in Ishares Tr over time
0.01%4,900
$242.1K
0.01%
new position